B34. ILD CELLULAR MECHANISMS

A Prospective Randomized, Multicenter Trial Evaluating the Efficacy and Safety of Combined Therapy with Pirfenidone and Inhaled N-Acetylcysteine for Idiopathic Pulmonary Fibrosis

Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3064 K. Kataoka, S. Sakamoto, Yasuhiro Kondoh, Kazuhisa Takahashi, Tomoaki Hoshino, Hiroshi Mukae, Masashi Bando, T. Suda, T. Kido, Y. Tanino, T. Kishaba, Noboru Hattori, Yoshio Taguchi, T. Saito, Yasuhiko Nishioka, K. Kuwano, K. Kishi, N. Inase, Sei Sasaki, Hajime Takizawa, T. Johkoh, F. Sakai, S. Homma

Galactic-1: A Randomized, Double-Blind, Multicentre, Parallel, Placebo-Controlled Phase 2b Study in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of TD139, an Inhaled Galectin-3 Inhibitor Administered via a Dry Powder Inhaler Over 52 Weeks

Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3065 A. Mackinnon, S. Khindri, N. Hirani, H. Leffler, U. Nilsson, T. Sethi, A. Pedersen, H. Schambye, C. McClinton, R. Slack, T. Maher

Upregulation of S100 Calcium Binding Protein A9 Levels in the Lungs of Patients with Idiopathic Pulmonary Fibrosis

Pub Date : 2020-04-03 DOI: 10.21203/rs.3.rs-20772/v1 Jong-Uk Lee, Jong-Sook Park, Myung-Shin Kim, Jai-Seong Park, Eun-Suk Go, H. Chang, Choon S. Park